Patents by Inventor Nikolaus Leist

Nikolaus Leist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11793419
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: October 24, 2023
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Publication number: 20230076111
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: November 14, 2022
    Publication date: March 9, 2023
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy FRANK, Nikhil PARGAONKAR, Raymond SCHMIDT, Robert AZEVEDO, Kurt SCHEINPFLUG, Nikolaus LEIST, Chris DONG, Hiren PATEL, Peter BJELETICH, Robert DUCK
  • Patent number: 11529071
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: December 20, 2022
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Publication number: 20210212592
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: September 28, 2020
    Publication date: July 15, 2021
    Applicant: Otsuka America Pharmaceutical, Inc.
    Inventors: Jeremy FRANK, Nikhil PARGAONKAR, Raymond SCHMIDT, Robert AZEVEDO, Kurt SCHEINPFLUG, Nikolaus LEIST, Chris DONG, Hiren PATEL, Peter BJELETICH, Robert DUCK
  • Patent number: 10820831
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: November 3, 2020
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Publication number: 20190167595
    Abstract: In some embodiments, a composition of matter includes aripiprazole, a metal selected from the group consisting of magnesium, zinc, sodium, lithium, iron, or alloys thereof, or combinations thereof and a copper salt selected from the group consisting of copper iodide, copper chloride, copper bromide, copper sulfate, copper formate, or combinations thereof.
    Type: Application
    Filed: October 25, 2018
    Publication date: June 6, 2019
    Applicant: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Mark ZDEBLICK, Markus CHRISTEN, Nikhil PARGAONKAR, Nikolaus LEIST, Kurt SCHEINPFLUG, Patricia JOHNSON, Benedict COSTELLO
  • Publication number: 20180110441
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: October 26, 2017
    Publication date: April 26, 2018
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich